References
Saxena A, Yan TD, Chua TC, Morris DL. Critical assessment of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol. 2010.
Elias D, Laurent S, Antoun S, Duvillard P, Ducreux M, Pocard M, et al. Pseudomyxoma peritonei treated with complete resection and immediate intraperitoneal chemotherapy. Gastroenterol Clin Biol. 2003;27:407–12.
Lutton NJ, Moran BJ. Hyperthermic intraperitoneal chemotherapy and cytoreductive surgery for peritoneal carcinomatosis of colorectal origin: a novel treatment strategy with promising results in selected patients. Cancer Treat Res. 2007;134:319–28.
Elias D, Goere D, Blot F, Billard V, Pocard M, Kohneh-Shahri N, et al. Optimization of hyperthermic intraperitoneal chemotherapy with oxaliplatin plus irinotecan at 43 degrees C after complete cytoreductive surgery: mortality and morbidity in 106 consecutive patients. Ann Surg Oncol. 2007;14:1818–24.
Elias D, Raynard B, Boige V, Laplanche A, Estphan G, Malka D, et al. Impact of the extent and duration of cytoreductive surgery on postoperative hematological toxicity after intraperitoneal chemohyperthermia for peritoneal carcinomatosis. J Surg Oncol. 2005;90:220–5.
Lee JC, Peitzman AB. Damage-control laparotomy. Curr Opin Crit Care. 2006;12:346–50.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pocard, M., Eveno, C. & Valleur, P. Regarding “Two Steps Procedure for Pseudomyxoma”. Ann Surg Oncol 18, 282–283 (2011). https://doi.org/10.1245/s10434-010-1193-y
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-010-1193-y